- Home
- DNLI vs RPD Comparison
DNLI vs RPD Comparison
Compare DNLI & RPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- RPD
- Stock Information
- Founded
- DNLI 2013
- RPD 2000
- Country
- DNLI United States
- RPD United States
- Employees
- DNLI N/A
- RPD N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- RPD Computer Software: Prepackaged Software
- Sector
- DNLI Health Care
- RPD Technology
- Exchange
- DNLI Nasdaq
- RPD Nasdaq
- Market Cap
- DNLI 1.8B
- RPD 1.5B
- IPO Year
- DNLI 2017
- RPD 2015
- Fundamental
- Price
- DNLI $12.74
- RPD $22.56
- Analyst Decision
- DNLI Strong Buy
- RPD Buy
- Analyst Count
- DNLI 16
- RPD 21
- Target Price
- DNLI $37.57
- RPD $38.89
- AVG Volume (30 Days)
- DNLI 1.7M
- RPD 1.1M
- Earning Date
- DNLI 05-06-2025
- RPD 05-12-2025
- Dividend Yield
- DNLI N/A
- RPD N/A
- EPS Growth
- DNLI N/A
- RPD N/A
- EPS
- DNLI N/A
- RPD 0.40
- Revenue
- DNLI N/A
- RPD $844,007,000.00
- Revenue This Year
- DNLI N/A
- RPD $3.61
- Revenue Next Year
- DNLI $372.05
- RPD $4.80
- P/E Ratio
- DNLI N/A
- RPD $56.40
- Revenue Growth
- DNLI N/A
- RPD 8.53
- 52 Week Low
- DNLI $10.57
- RPD $22.08
- 52 Week High
- DNLI $33.33
- RPD $46.96
- Technical
- Relative Strength Index (RSI)
- DNLI 42.15
- RPD 32.18
- Support Level
- DNLI $12.37
- RPD $22.44
- Resistance Level
- DNLI $13.63
- RPD $24.48
- Average True Range (ATR)
- DNLI 1.24
- RPD 1.41
- MACD
- DNLI 0.23
- RPD -0.06
- Stochastic Oscillator
- DNLI 50.94
- RPD 8.77
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About RPD Rapid7 Inc.
Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.